Predictors of clinical effectiveness of Hymenoptera venom immunotherapy.

scientific article published in January 2014

Predictors of clinical effectiveness of Hymenoptera venom immunotherapy. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/CEA.12275
P698PubMed publication ID24447114

P50authorHelmut KüchenhoffQ52699954
Andreas BenderQ43680511
P2093author name stringK Sotlar
H-P Horny
F Ruëff
B Przybilla
M Flaig
R Chatelain
S Dugas-Breit
B Vos
A Linhardt
E Stretz
J Oude Elberink
R Vollrath
S Mastnik
P2860cites workPatients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom dosesQ43821997
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levelsQ43992711
Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practiceQ46787767
Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedemaQ47814416
Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.Q50871797
Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safetyQ52445480
Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.Q52687592
Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom HypersensitiQ52699890
Influence of total and specific IgE, serum tryptase, and age on severity of allergic reactions to Hymenoptera stingsQ52709943
A new look at the statistical model identificationQ26778401
Diagnostic criteria and classification of mastocytosis: a consensus proposalQ33948617
Stinging insect hypersensitivity: a practice parameter update 2011.Q34175153
Clinical features and severity grading of anaphylaxisQ34341881
Diagnosis of Hymenoptera venom allergyQ34561401
Clinical effectiveness of hymenoptera venom immunotherapy: a prospective observational multicenter study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivityQ34735017
Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposalQ35574171
Mastocytosis and Hymenoptera venom allergyQ36529604
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteriaQ36835061
Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapyQ37559690
Mastocytosis and insect venom allergyQ37756473
Diagnosis and treatment of allergy to hymenoptera venomsQ37764668
Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.Q37873485
Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria.Q37876117
New topics in bradykinin research.Q37920922
Incidence and severity of anaphylactoid reactions to colloid volume substitutesQ39423931
Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelinesQ39716681
Discontinuing venom immunotherapy: extended observationsQ41731183
Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase.Q41987845
Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapyQ42447122
Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stingsQ43531335
P433issue5
P921main subjectHymenopteraQ22651
immunotherapyQ1427096
venomQ3386847
P304page(s)736-746
P577publication date2014-01-01
P1433published inClinical & Experimental AllergyQ5133747
P1476titlePredictors of clinical effectiveness of Hymenoptera venom immunotherapy
P478volume44

Reverse relations

cites work (P2860)
Q345001522015 update of the evidence base: World Allergy Organization anaphylaxis guidelines
Q38364807Anaphylaxis and cardiovascular disease: therapeutic dilemmas
Q42476004Anaphylaxis with clonal mast cells in normal looking skin - a new entity?
Q52769907Changing practice: no need to stop ACE inhibition for venom immunotherapy.
Q89537659Clinical Utility of Rush Venom Immunotherapy: Current Status
Q34669524Clinical contraindications to allergen immunotherapy: an EAACI position paper
Q40940984Developments in the field of allergy in 2014 through the eyes of Clinical and Experimental Allergy.
Q38658310EAACI Guidelines on Allergen Immunotherapy: Hymenoptera venom allergy.
Q93186376Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
Q37608704Hymenoptera allergens: from venom to "venome".
Q35153623Long-lasting complete response to imatinib in a patient with systemic mastocytosis exhibiting wild type KIT.
Q38627901Overcoming severe adverse reactions to venom immunotherapy by using anti-IgE antibodies in combination with a high maintenance dose
Q30371972Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement
Q33645878Safety and efficacy of venom immunotherapy: a real life study
Q104616203Safety and tolerability of venom immunotherapy: Evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy)
Q51533907Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI Task Force Consensus Statement.
Q49821513Venom Immunotherapy in High-Risk Patients: The Advantage of the Rush Build-Up Protocol
Q38505192Venom immunotherapy: clinical efficacy, safety and contraindications.
Q91176197Worldwide perspectives on venom allergy
Q52779212[Sting challenge: indications and execution].

Search more.